跳至主要内容
临床试验/PACTR202304865602085
PACTR202304865602085尚未招募3 期

Efficacy and safety of preemptive intrathecal morphine versus nalbuphine in lumbar spine surgery: A randomized clinical trial.

Dr. Mona Raafat Elghamry0 个研究点目标入组 88 人开始时间: 2023年3月19日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • ASA physical status I &II
  • age range 30-60 years old
  • scheduled to undergo elective open posterior lumbar interbody fusion surgery at 1 or 2 level

排除标准

  • Body mass index >35 kg/m2.
  • Patients with neurological deficit (symptoms of lumbar intervertebral nerve injury (determined by a neurosurgical specialist based on physical and imaging examinations).
  • Redo or previous lumber surgery.
  • Allergy or contraindication to the given study drugs.
  • Patients on chronic pain medication.
  • Chronic alcoholism, history of a major psychiatric disorder or cognitive disorder (inability to understand the VAS).
  • Any contraindication to intrathecal injection.

研究者

发起方
Dr. Mona Raafat Elghamry

相似试验